Viewing Study NCT05555303


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-06-01 @ 4:39 PM
Study NCT ID: NCT05555303
Status: RECRUITING
Last Update Posted: 2023-03-29
First Post: 2022-09-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis
Sponsor: Rwanda Biomedical Centre
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tuberculosis, Multidrug-Resistant View
Keywords:

Keywords

Keyword Brief Keyword Text View
None multidrug- and rifampicin-resistant tuberculosis View